NBY - NovaBay Pharmaceuticals, Inc.
1.48
0.050 3.378%
Share volume: 261,107
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$1.43
0.05
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-07-2024 | 05-15-2025 | 08-14-2025 | 11-07-2025 | |
| Cash flow financing | 2.089 M | -1.708 M | -174.000 K | -1.319 M | |
| Other financing cash flows | 21.000 K | 614.000 K | 0.000 | 237.000 K | |
| Cash flow | 26.000 K | -3.032 M | 0.000 | 0.000 | |
| Net income | -1.212 M | 7.670 M | -1.922 M | -1.293 M | |
| Depreciation | 9.000 K | 2.000 K | 1.000 K | 2.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -2.000 K | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.000 K | 0.000 | 0.000 | 0.000 | |
| Cash Change | 26.000 K | -3.032 M | 7.946 M | -3.119 M |